Free Trial

Galmed Pharmaceuticals (GLMD) Short Interest Ratio & Short Volume

$0.37
+0.01 (+2.78%)
(As of 05/31/2024 ET)

Galmed Pharmaceuticals Short Interest Data

Current Short Interest
72,800 shares
Previous Short Interest
83,800 shares
Change Vs. Previous Month
-13.13%
Dollar Volume Sold Short
$27,918.80
Short Interest Ratio
0.4 Days to Cover
Last Record Date
May 15, 2024
Outstanding Shares
5,050,000 shares
Float Size
5,780,000 shares
Short Percent of Float
1.26%
Today's Trading Volume
33,007 shares
Average Trading Volume
151,496 shares
Today's Volume Vs. Average
22%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Galmed Pharmaceuticals ?

Sign up to receive the latest short interest report for Galmed Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

GLMD Short Interest Over Time

GLMD Days to Cover Over Time

GLMD Percentage of Float Shorted Over Time

Galmed Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
5/15/202472,800 shares $27,918.80 -13.1%1.3%0.4 $0.38
4/30/202483,800 shares $29,497.60 +6.1%1.5%0.4 $0.35
4/15/202479,000 shares $30,012.10 +101.5%2.2%0.4 $0.38
3/31/202439,200 shares $13,574.96 +532.3%1.1%0.2 $0.35
3/15/20246,200 shares $1,891.62 -84.9%0.2%0 $0.31
2/29/202441,000 shares $16,322.10 -46.1%1.2%0.4 $0.40
2/15/202476,000 shares $28,887.60 +560.9%2.1%0.6 $0.38
1/31/202411,500 shares $4,311.35 -79.1%0.3%0.1 $0.37
1/15/202455,100 shares $25,015.40 -9.7%1.5%0.3 $0.45
12/31/202361,000 shares $27,755.00 +65.3%1.7%0.4 $0.46
12/15/202336,900 shares $13,165.92 -56.9%1.0%0.2 $0.36
11/30/202385,700 shares $30,423.50 +564.3%2.4%0.4 $0.36
11/15/202312,900 shares $5,160.00 +17.3%0.4%0.1 $0.40
10/31/202311,000 shares $4,180.00 -1.8%0.3%0.2 $0.38
10/15/202311,200 shares $4,592.00 +75.0%0.3%0.1 $0.41
9/30/20236,400 shares $3,968.00 +88.2%0.2%0 $0.62
9/15/20233,400 shares $2,515.66 -52.8%0.1%0 $0.74
8/31/20237,200 shares $5,824.80 -32.7%0.2%0 $0.81
8/15/202310,700 shares $8,669.14 -61.1%0.3%0 $0.81
7/31/202327,500 shares $31,625.00 -92.3%1.5%0.1 $1.15
7/15/2023357,100 shares $517,795.00 +2,668.2%20.1%1.3 $1.45
6/30/202312,900 shares $37,539.00 -6.5%0.9%0.1 $2.91
6/15/202313,800 shares $51,474.00 -14.3%1.0%0.5 $3.73
5/31/202316,100 shares $74,221.00 -18.7%1.1%0.7 $4.61
5/15/202319,800 shares $0.00 +1,700.0%1.4%0.9 $0.00
4/30/202317,200 shares $5,332.00 -6.5%0.1%0.1 $0.31
4/15/202318,400 shares $5,704.00 -30.3%0.1%0.3 $0.31
3/31/202326,400 shares $11,259.60 -28.5%0.1%0.3 $0.43
3/15/202336,900 shares $17,239.68 +58.4%0.2%0.3 $0.47
2/28/202323,300 shares $11,184.00 -32.1%0.1%0.2 $0.48
2/15/202334,300 shares $20,923.00 +106.6%0.2%0.2 $0.61
1/31/202316,600 shares $10,974.26 -88.4%0.1%0.1 $0.66
1/15/2023143,500 shares $115,058.30 -2.3%0.7%1.1 $0.80
12/30/2022146,900 shares $73,450.00 +57.3%0.7%1.3 $0.50
12/15/202293,400 shares $27,086.00 +233.6%0.4%1.1 $0.29
11/30/202228,000 shares $8,173.20 +53.0%0.1%0.8 $0.29
11/15/202218,300 shares $6,101.22 -45.9%0.1%0.4 $0.33
10/31/202233,800 shares $12,847.38 +80.8%0.2%0.6 $0.38
10/15/202218,700 shares $7,264.95 +22.2%0.1%0.3 $0.39
9/30/202215,300 shares $4,759.59 -57.5%0.1%0.2 $0.31
Write this ticker symbol down… (Ad)

A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.

Discover the #1 company leading this revolution
9/15/202236,000 shares $16,563.60 -35.5%0.2%0.4 $0.46
8/31/202255,800 shares $25,896.78 +234.1%0.3%0.5 $0.46
8/15/202216,700 shares $7,424.82 -34.0%0.1%0.2 $0.44
7/31/202225,300 shares $12,703.13 -29.3%0.1%0.2 $0.50
7/15/202235,800 shares $21,651.84 -66.4%0.2%0.3 $0.60
6/30/2022106,600 shares $69,290.00 -0.7%0.5%0.9 $0.65
6/15/2022107,300 shares $48,285.00 +364.5%0.5%1.1 $0.45
5/31/202223,100 shares $11,817.96 -0.4%0.1%0.2 $0.51
5/15/202223,200 shares $14,105.60 -27.3%0.1%0.3 $0.61
4/30/202231,900 shares $52,954.00 -37.6%0.2%0.4 $1.66
4/15/202251,100 shares $83,293.00 -6.2%0.2%0.9 $1.63
3/31/202254,500 shares $86,655.00 -47.3%0.3%0.5 $1.59
3/15/2022103,500 shares $127,305.00 -36.0%0.5%0.8 $1.23
2/28/2022161,700 shares $232,848.00 -30.9%0.8%1.2 $1.44
2/15/2022234,100 shares $374,560.00 -17.9%1.1%1.7 $1.60
1/31/2022285,200 shares $462,024.00 +21.7%1.3%1.8 $1.62
1/15/2022234,300 shares $374,880.00 +20.5%N/A1.3 $1.60
12/31/2021194,400 shares $353,808.00 -36.4%1.0%1.1 $1.82
12/15/2021305,500 shares $653,770.00 +7.0%1.5%2.5 $2.14
11/30/2021285,600 shares $719,712.00 -15.6%1.4%2.4 $2.52
11/15/2021338,500 shares $1.01 million +24.6%1.7%2.7 $2.98
10/29/2021271,700 shares $671,099.00 -16.9%1.3%2.2 $2.47
10/15/2021326,900 shares $898,975.00 +2.7%1.6%1.4 $2.75
9/30/2021318,300 shares $888,057.00 -17.0%1.6%1.4 $2.79
9/15/2021383,700 shares $1.12 million -10.8%1.9%1.6 $2.91
8/31/2021430,100 shares $1.41 million -8.0%2.1%1.7 $3.27
8/13/2021467,500 shares $1.38 million -28.5%2.3%1.4 $2.95
7/30/2021654,000 shares $1.63 million +0.8%3.3%1.8 $2.49
7/15/2021648,700 shares $1.69 million -0.6%3.2%2.4 $2.61
6/30/2021652,500 shares $1.98 million +23.6%3.3%2.3 $3.04
6/15/2021527,900 shares $1.68 million +97.9%2.6%1.8 $3.18
5/28/2021266,800 shares $693,680.00 -1.4%1.3%0.8 $2.60
5/14/2021270,700 shares $606,368.00 -16.4%1.4%1 $2.24
4/30/2021323,900 shares $1.09 million -2.4%1.6%0.8 $3.37
4/15/2021331,700 shares $1.09 million +15.1%1.7%0.8 $3.30
3/31/2021288,300 shares $960,039.00 +30.2%1.5%0.7 $3.33
3/15/2021221,500 shares $775,250.00 +14.8%1.1%0.5 $3.50
2/26/2021192,900 shares $792,819.00 +389.6%1.1%0.5 $4.11
2/12/202139,400 shares $212,760.00 +4.2%0.2%0.1 $5.40
1/29/202137,800 shares $142,695.00 +49.4%0.2%0.2 $3.78
1/15/202125,300 shares $88,044.00 -22.6%0.2%0.2 $3.48
12/31/202032,700 shares $106,929.00 +26.3%0.2%0.3 $3.27
12/15/202025,900 shares $94,794.00 -29.0%0.2%0.3 $3.66
11/30/202036,500 shares $152,205.00 +55.3%0.2%0.5 $4.17
11/15/202023,500 shares $79,665.00 +109.8%0.2%0.3 $3.39
10/30/202011,200 shares $34,384.00 -49.6%0.1%0.2 $3.07
10/15/202022,200 shares $74,370.00 -53.0%0.1%0.3 $3.35
9/30/202047,200 shares $166,616.00 -28.9%0.3%0.5 $3.53
9/15/202066,400 shares $278,880.00 -65.2%0.4%0.8 $4.20
8/31/2020191,000 shares $932,080.00 -56.7%1.2%2.3 $4.88
Write this ticker symbol down… (Ad)

A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made millionaire Tim Bohen is giving you an inside look at the megatrend that’s going to change everything.

Discover the #1 company leading this revolution
8/14/2020441,500 shares $2.09 million -3.0%2.8%5.1 $4.74
7/31/2020455,100 shares $2.21 million -2.5%2.9%4.6 $4.85
7/15/2020466,700 shares $2.20 million +0.3%3.2%5.2 $4.72
6/30/2020465,500 shares $2.25 million +23.8%3.2%5.8 $4.84
6/15/2020376,000 shares $1.85 million +1.1%2.5%4.5 $4.92
5/29/2020372,000 shares $1.77 million -4.6%2.5%4 $4.75
5/15/2020389,900 shares $1.98 million +3.5%2.6%4 $5.09
4/30/2020376,900 shares $1.64 million -0.3%2.6%4.5 $4.36
4/15/2020378,200 shares $1.62 million +1.3%2.6%4.2 $4.29
3/31/2020373,300 shares $1.69 million +0.6%2.5%4 $4.53
3/13/2020371,000 shares $1.37 million -10.4%2.5%4.1 $3.68
2/28/2020414,100 shares $1.51 million -1.4%2.7%4.6 $3.64
2/14/2020420,000 shares $2.10 million +4.1%2.9%3.7 $4.99
1/31/2020403,600 shares $2.16 million -7.2%2.7%3.7 $5.36
1/15/2020434,700 shares $2.52 million -4.7%3.0%3.8 $5.79
12/31/2019455,900 shares $2.63 million -2.1%3.1%4 $5.77

GLMD Short Interest - Frequently Asked Questions

What is Galmed Pharmaceuticals' current short interest?

Short interest is the volume of Galmed Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 72,800 shares of GLMD short. 1.26% of Galmed Pharmaceuticals' shares are currently sold short. Learn More on Galmed Pharmaceuticals' current short interest.

What is a good short interest percentage for Galmed Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.26% of Galmed Pharmaceuticals' floating shares are currently sold short.

Is Galmed Pharmaceuticals' short interest increasing or decreasing?

Galmed Pharmaceuticals saw a decline in short interest in May. As of May 15th, there was short interest totaling 72,800 shares, a decline of 13.1% from the previous total of 83,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Galmed Pharmaceuticals' float size?

Galmed Pharmaceuticals currently has issued a total of 5,050,000 shares. Some of Galmed Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Galmed Pharmaceuticals currently has a public float of 5,780,000 shares.

How does Galmed Pharmaceuticals' short interest compare to its competitors?

1.26% of Galmed Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Galmed Pharmaceuticals: ASLAN Pharmaceuticals Limited (1.38%), First Wave BioPharma, Inc. (2.39%), Trevena, Inc. (0.11%), Longeveron Inc. (3.09%), Shuttle Pharmaceuticals Holdings, Inc. (0.43%), Protagenic Therapeutics, Inc. (0.27%), Pulmatrix, Inc. (0.01%), Tenax Therapeutics, Inc. (0.52%), TFF Pharmaceuticals, Inc. (4.44%), Ainos, Inc. (3.43%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks.

What does it mean to sell short Galmed Pharmaceuticals stock?

Short selling GLMD is an investing strategy that aims to generate trading profit from Galmed Pharmaceuticals as its price is falling. GLMD shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Galmed Pharmaceuticals?

A short squeeze for Galmed Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GLMD, which in turn drives the price of the stock up even further.

How often is Galmed Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GLMD, twice per month. The most recent reporting period available is May, 15 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:GLMD) was last updated on 5/31/2024 by MarketBeat.com Staff

From Our Partners